1. Home
  2. BNR vs CSBR Comparison

BNR vs CSBR Comparison

Compare BNR & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$9.40

Market Cap

94.4M

Sector

Health Care

ML Signal

N/A

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$6.06

Market Cap

81.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
CSBR
Founded
2014
1985
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.4M
81.0M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
BNR
CSBR
Price
$9.40
$6.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.1K
5.6K
Earning Date
06-05-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
161.11
EPS
N/A
N/A
Revenue
N/A
$2,900,000.00
Revenue This Year
$111.65
$4.84
Revenue Next Year
N/A
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.31
$5.50
52 Week High
$41.72
$8.74

Technical Indicators

Market Signals
Indicator
BNR
CSBR
Relative Strength Index (RSI) 46.02 53.66
Support Level $8.34 $6.11
Resistance Level $10.00 $6.29
Average True Range (ATR) 0.78 0.27
MACD -0.01 0.03
Stochastic Oscillator 17.10 98.36

Price Performance

Historical Comparison
BNR
CSBR

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: